Thrivent Financial for Lutherans Has $35.48 Million Stock Holdings in CorVel Corp. $CRVL

Thrivent Financial for Lutherans lifted its stake in shares of CorVel Corp. (NASDAQ:CRVL) by 14.6% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 458,326 shares of the business services provider’s stock after purchasing an additional 58,323 shares during the quarter. Thrivent Financial for Lutherans owned 0.89% of CorVel worth $35,484,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. State Street Corp raised its position in shares of CorVel by 1.9% in the 2nd quarter. State Street Corp now owns 1,093,710 shares of the business services provider’s stock valued at $112,412,000 after buying an additional 20,537 shares in the last quarter. Geode Capital Management LLC increased its stake in CorVel by 5.3% in the second quarter. Geode Capital Management LLC now owns 845,660 shares of the business services provider’s stock valued at $86,925,000 after acquiring an additional 42,861 shares during the last quarter. Norges Bank acquired a new position in CorVel during the second quarter valued at approximately $34,418,000. Bank of New York Mellon Corp lifted its stake in CorVel by 2.3% during the second quarter. Bank of New York Mellon Corp now owns 176,927 shares of the business services provider’s stock worth $18,185,000 after purchasing an additional 4,001 shares during the last quarter. Finally, Assenagon Asset Management S.A. boosted its holdings in shares of CorVel by 68.8% in the 3rd quarter. Assenagon Asset Management S.A. now owns 172,932 shares of the business services provider’s stock valued at $13,388,000 after purchasing an additional 70,454 shares in the last quarter. Institutional investors and hedge funds own 51.36% of the company’s stock.

CorVel Stock Up 0.2%

Shares of CRVL opened at $69.75 on Tuesday. The stock has a market cap of $3.57 billion, a PE ratio of 34.36 and a beta of 1.06. CorVel Corp. has a 12-month low of $65.47 and a 12-month high of $128.61. The business has a 50-day simple moving average of $69.70 and a two-hundred day simple moving average of $77.27.

CorVel (NASDAQ:CRVL) last released its quarterly earnings results on Tuesday, November 4th. The business services provider reported $0.54 earnings per share for the quarter. CorVel had a return on equity of 31.72% and a net margin of 11.28%.The company had revenue of $239.64 million for the quarter.

Analyst Ratings Changes

Several brokerages recently weighed in on CRVL. Wall Street Zen downgraded CorVel from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Weiss Ratings reissued a “hold (c)” rating on shares of CorVel in a report on Friday, January 9th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.

Insider Activity at CorVel

In other news, EVP Mark E. Bertels sold 1,200 shares of CorVel stock in a transaction on Wednesday, November 19th. The shares were sold at an average price of $72.35, for a total transaction of $86,820.00. Following the transaction, the executive vice president owned 2,594 shares in the company, valued at approximately $187,675.90. The trade was a 31.63% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director R Judd Jessup sold 7,076 shares of the business’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $76.94, for a total transaction of $544,427.44. Following the completion of the sale, the director directly owned 115,045 shares in the company, valued at approximately $8,851,562.30. This represents a 5.79% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 11,733 shares of company stock valued at $894,686. Corporate insiders own 44.56% of the company’s stock.

CorVel Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).